DNA sequence useful for the detection of Alzheimer's disease
AssigneeScios Nova Inc.
InventorsPhyllis A. Ponte, Barbara Cordell
Life of this patent
Estimating the term…
Abstract
DNA sequences encoding the beta-amyloid core protein, and beta-amyloid-related proteins associated with Alzheimer's disease are disclosed. These sequences are used in producing or constructing recombinant beta-amyloid core protein, beta-amyloid-related proteins and recombinant or synthetic immunogenic peptides. These sequences are also used to identify genomic mutations and/or restriction site alterations which are associated with a predisposition to Alzheimer's disease, for purposes of genetic screening. Antibodies generated against the recombinant proteins or immunogenic peptides derived therefrom can be used for cerebral fluid or serum protein diagnosis of Alzheimer's disease.
Claims5
An isolated native, cloned recombinant or synthetic DNA sequence useful in the prognosis and diagnosis of Alzheimer's disease in human subjects comprising the DNA sequence of FIG. 1.
An isolated native, cloned recombinant or synthetic DNA sequence corresponding to nucleotides 864 to 1035 in FIG. 1.
Dependencies are inferred from the claim text.